YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

BACKGROUND: Definitive chemoradiation therapy (dCRT) is the standard treatment for patients with nonsurgical esophageal squamous cell carcinoma (ESCC), yet patients have demonstrated great variations in their responses to dCRT and inevitably progressed following treatment. METHODS: To identify progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Honghai, Shao, Yang W., Tong, Xiaoling, Wu, Xue, Pang, Jiaohui, Feng, Alei, Yang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050074/
https://www.ncbi.nlm.nih.gov/pubmed/31851786
http://dx.doi.org/10.1002/cam4.2761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050074/
https://www.ncbi.nlm.nih.gov/pubmed/31851786
http://dx.doi.org/10.1002/cam4.2761

Ejemplares similares